Nations with high rates of coronavirus testing such as South Korea and Germany are also leading the world in commercialising COVID-19 diagnostic tests – far outstripping the domestic UK and US diagnostic industries, new research shows.

The most affected group were young people aged 18-24 years, with more than four in ten (44 per cent) saying they felt lonely, according to the research study.

The Global Engagement Networks will develop practical solutions to address issues such as the prevalence of single-use plastic in Kenya, hurricane recovery in the Caribbean and water management across Africa.

Despite the challenges presented by the nationwide shift towards remote working, the Team has worked hard behind the scenes to ensure that the popular and highly regarded training sessions can still continue to take place for organisations impacted by COVID-19.

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that its cGMP-compliant CHOSOURCE™ platform has played a key role in generating a stable cell line for the development of an immunotherapy for autoimmune

Looking for something specific?

Nations with high rates of coronavirus testing such as South Korea and Germany are also leading the world in commercialising COVID-19 diagnostic tests – far outstripping the domestic UK and US diagnostic industries, new research shows.

The most affected group were young people aged 18-24 years, with more than four in ten (44 per cent) saying they felt lonely, according to the research study.

The Global Engagement Networks will develop practical solutions to address issues such as the prevalence of single-use plastic in Kenya, hurricane recovery in the Caribbean and water management across Africa.

Despite the challenges presented by the nationwide shift towards remote working, the Team has worked hard behind the scenes to ensure that the popular and highly regarded training sessions can still continue to take place for organisations impacted by COVID-19.

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that its cGMP-compliant CHOSOURCE™ platform has played a key role in generating a stable cell line for the development of an immunotherapy for autoimmune